ORBIMED ADVISORS LLC 13D and 13G filings for Aerpio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-11-12 5:15 pm Purchase | 2020-11-10 | 13D | Aerpio Pharmaceuticals, Inc. ARPO | ORBIMED ADVISORS LLC | 346,263 11.000% | 346,263 (New Position) | Filing |